(Panel 2) High-Level Meeting on antimicrobial…

Guiding Questions:

• Question 1: What are the current gaps in the surveillance of AMR and antimicrobial use?
  How can we enhance integrated surveillance systems for a better informed and more cost effective policy-decision making?
• Question 2: What capacity-building resources are essential for preventing and addressing AMR in specific sectors and across sectors? What strategies should be put in place to ensure countries have adequate capacities, resources, and skills to efficiently implement and evaluate their national AMR response, including their national action plans (NAPs) on AMR?
• Question 3: How can we sustainably fund our response to AMR particularly at the national
  level? What financial mechanisms or innovations could be leveraged for AMR financing
  at global, regional and national levels?
• Question 4: How can we improve coordination on the AMR response and synergies with
  other agendas such as environment, food security, and water, sanitation and hygiene
  (WASH)?
• Question 5: What role can the private sector play in achieving equitable access to
  antimicrobials and complementary diagnostics, therapeutics and vaccines? What measures need to be implemented to ensure a sustainable R&D pipeline and roll out of
  new antimicrobials, as well as alternatives to antimicrobials?

The High-level Meeting on Antimicrobial Resistance is convened by the President of the General Assembly. Theme: Investing in the present and securing our future together: accelerating multisectoral global, regional and national actions to address antimicrobial resistance.

Drug-resistant infections know no borders, meaning no single country can respond to AMR alone. This meeting is an important opportunity for world leaders to collectively address the looming threat AMR poses to global health, food security, and achieving the 2030 Sustainable Development Goals.

The High-level Meeting will consist of an opening segment, a plenary, two interactive multi-stakeholder panels, and a closing segment.

The high-level meeting is expected to approve a concise and action-oriented political declaration with a shared vision including the consideration of measurable targets and objectives on mobilizing political will and action to address the drivers, sources and challenges of antimicrobial resistance, agreed in advance by consensus through intergovernmental negotiations, to be submitted by the President of the General Assembly for adoption by the Assembly.

In 2016 the first high-level meeting on AMR resulted in a political declaration that laid the foundation for global action against Antimicrobial Resistance (AMR).

According to the World Health Organization, AMR is one of the top global public health and development threats. It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019.

The World Bank estimates that it could result in US$ 1 trillion additional healthcare costs by 2050, and up to US$ 3.4 trillion gross domestic product (GDP) losses per year by 2030.